Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study

Journal:

Journal of Clinical Oncology

Published:

2026-05-27

DOI:

10.1200/jco-25-03045

Affiliations:

27

Authors:

22

Go to article

Institutions	Authors	Share
Georges Pompidou European Hospital (HEGP), France	1.833333	0.08
Paris Cité University, France	1.833333	0.08
Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie (Association ARTIC), France	1.000000	0.05
Molecular Predictors and New Targets in Oncology, France	1.000000	0.05
Centre Léon Bérard (CLB), France	1.000000	0.05
University Hospitals of Strasbourg (HUS), France	1.000000	0.05
Centre Eugène Marquis (CEM), France	1.000000	0.05
Unité Mixte de Recherche RIGHT, France	1.000000	0.05
Centre Hospitalier Régional Universitaire de TOURS (CHRU de Tours), France	1.000000	0.05
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.05
Bégin Military Teaching Hospital (HIA), France	1.000000	0.05
Vivalto Santé, France	1.000000	0.05
Cancer Research Center of Marseille (CRCM), France	1.000000	0.05
St Andrew's Hospital, France	1.000000	0.05
Cochin Hospital, France	1.000000	0.05
CHRU de Besançon, France	1.000000	0.05
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France	1.000000	0.05
Curie Institute, France	1.000000	0.05
SIRIC CARPEM, France	0.500000	0.02
Centre Antoine-Lacassagne (CAL), France	0.500000	0.02
Université Côte d'Azur (UniCA), France	0.500000	0.02
Cordelier Research Center (CRC), France	0.500000	0.02
Paris-Cardiovascular Research Center (PARCC), France	0.333333	0.02

Interested in Oncology and Carcinogenesis?